Minneapolis, MN, United States of America

Ernesto Ruben Resnik

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Ernesto Ruben Resnik

Introduction

Ernesto Ruben Resnik is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 2 patents, his work has advanced the understanding and application of these important biological tools.

Latest Patents

Resnik's latest patents include innovations related to hybridoma clones and monoclonal antibodies targeting VSIG-4. These patents describe monoclonal antibodies that bind to VSIG-4, including those that block the binding of VSIG-4 to SIGLEC-7. The patents also cover compositions that include these monoclonal antibodies, as well as methods for making and using them.

Career Highlights

Resnik is currently associated with Bio-Techne Corporation, where he continues to push the boundaries of biotechnological research. His work has been instrumental in developing new therapeutic approaches that leverage the power of monoclonal antibodies.

Collaborations

Some of his notable coworkers include Birte Aggeler and Christine Goetz, who have collaborated with him on various projects within the biotechnology sector.

Conclusion

Ernesto Ruben Resnik's contributions to the field of biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of innovative therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…